Medication info
Kayrilm Tablets 1/250 mg

Kayrilm Tablets 1/250 mg

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›1mg / 1 tabletMetformin Hydrochloride›250mg / 1 tablet
Manufacturer / importer
KS Pharmaceutical Co., Ltd.
Appearance
White rectangular film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201908350 · Approved 2019.12.11 · Insurance code 059000110

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
This medicine should be administered 1~2 times daily immediately before or with meals. The dose may be adjusted according to each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, which may be adjusted based on the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose was glimepiride/metformin hydrochloride 2mg/500mg, and experience is available with gradual dose increases based on blood glucose monitoring results up to glimepiride/metformin hydrochloride 8mg/2000mg. With glimepiride as a single agent, additional effects are generally minimal at doses above 4mg per day, although some patients showed better metabolic control when the dose was increased to 6mg (or 8mg). When used as a replacement for combination therapy, administer based on the dosage and administration regimen of glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than a single dose at the next scheduled administration.

Ingredients

Manufacturer
KS Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication helps control blood sugar levels in patients with type 2 diabetes by using Glimiperide and Metformin together. It is used in conjunction with diet and exercise therapy to manage blood sugar effectively and assist in the treatment of diabetes.

How to take

Adult dose

This medicine should be administered 1~2 times daily immediately before or with meals. The dose may be adjusted according to each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is generally initiated at a low dose, which may be adjusted based on the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose was glimepiride/metformin hydrochloride 2mg/500mg, and experience is available with gradual dose increases based on blood glucose monitoring results up to glimepiride/metformin hydrochloride 8mg/2000mg. With glimepiride as a single agent, additional effects are generally minimal at doses above 4mg per day, although some patients showed better metabolic control when the dose was increased to 6mg (or 8mg). When used as a replacement for combination therapy, administer based on the dosage and administration regimen of glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than a single dose at the next scheduled administration.

Precautions

This medication may cause severe lactic acidosis or hypoglycemia; therefore, it should be discontinued and a doctor consulted, especially in cases of rapidly declining renal function. It is also safer to temporarily stop administration in the presence of dehydration symptoms, severe diarrhea, vomiting, or fever. Caution is needed when using it along with other medications that can affect renal function. This medication should not be administered to patients with insulin-dependent diabetes, acute metabolic acidosis, severe liver dysfunction, or during pregnancy and breastfeeding. Elderly patients or those with impaired renal function need dosage adjustments and regular renal function checks. In the early stages of treatment, there is a heightened risk of hypoglycemia, so one should be mindful of irregular meals, excessive exercise, and alcohol consumption. If hypoglycemic symptoms occur, sugar should be consumed immediately. This medication may cause various side effects such as gastrointestinal disturbances, allergic reactions, hematological abnormalities, and vitamin B12 deficiency; if any unusual symptoms occur, the physician should be consulted immediately. It is necessary to regularly check the condition of blood sugar control, and especially during stress situations such as surgery or infection, treatment methods may need to be adjusted. Furthermore, this medication can interact with several other drugs, so patients must inform healthcare personnel if they are taking any other medications. Do not use during pregnancy or breastfeeding, and exercise caution when administering to children or adolescents. In case of overdose, severe hypoglycemia or lactic acidosis may occur, necessitating immediate emergency treatment; dialysis may be effective. Keep this medication out of the reach of children and do not transfer it to another container. Finally, be cautious while driving or operating machinery due to the risk of hypoglycemia and other side effects.

Side effects

  • Lactic acidosis
  • hypoglycemia
  • diarrhea
  • nausea
  • vomiting
  • abdominal distension
  • loss of appetite
  • dyspepsia
  • constipation
  • abdominal pain
Show 71 more
  • metallic taste
  • visual impairment
  • taste disorder
  • erythema
  • itching
  • urticaria
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • anemia
  • agranulocytosis
  • pancytopenia
  • decreased vitamin B12
  • peripheral neuropathy
  • megaloblastic anemia
  • increased liver enzymes
  • liver damage
  • cholestasis
  • jaundice
  • hepatitis
  • allergic vasculitis
  • photosensitivity
  • decreased serum sodium concentration
  • hypothyroidism
  • magnesium deficiency due to diarrhea
  • encephalopathy
  • hair loss
  • weight gain
  • headache
  • severe hunger
  • fatigue
  • sleep disorders
  • instability
  • aggressiveness
  • attention deficit
  • inability to concentrate
  • abnormal reactions
  • depression
  • confusion
  • speech disorder
  • aphasia
  • tremors
  • paralysis
  • sensory disturbances
  • dizziness
  • inability to self-regulate
  • delirium
  • cerebral seizures
  • loss of consciousness
  • coma
  • weak breathing
  • bradycardia
  • sweating
  • moist skin
  • hypertension
  • palpitations
  • angina
  • deep vein thrombosis
  • dizziness
  • liver function abnormalities
  • prostatic hyperplasia
  • palpitations
  • dizziness
  • leg edema
  • cardiac arrest
  • rectal carcinoma
  • arthralgia
  • facial edema
  • erectile dysfunction
  • flushing
  • gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly sealed container to prevent air exposure, ideally at a temperature between 1 and 30 degrees Celsius. Proper storage helps maintain the medication's efficacy and prevent deterioration.

Appearance and packaging

Appearance

White rectangular film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.